Stay Alert for Hydroxyzine in Patients at Risk for Heart Problems

October 2016

Recent warnings and labeling changes are highlighting the risk of abnormal heartbeats with hydroxyzine (Vistaril, Atarax, etc).

There are reports that hydroxyzine prolongs the "QT interval" on an ECG heart monitor...increasing the risk for sudden death.

Fortunately it's rare...but you can help spot patients at risk.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Dosage Forms Pay Close Attention to Drug Names That Have Extended-Release Abbreviations
Storage & Disposal Flag Meds That Must Be Kept in Their Original Container
Medicare Point Out What's New For 2017 Medicare Part D Plans
Gout Help Ensure Patients Do Not Take the New Gout Drug Zurampic By Itself
Influenza Encourage Patients to Get Their Flu Vaccine by the End of October
Opioids Alert Your Pharmacist to Patients Getting Opioids and Benzodiazepines Together
Antithrombotics Find Out WHY Patients Are Taking Blood Thinners
Adverse Events Take Serotonin Syndrome Computer Alerts Seriously
Adverse Events Stay Alert for Hydroxyzine in Patients at Risk for Heart Problems
Pregnancy Ask About Pregnancy Status to Help Your Pharmacist Recommend Pain Treatments
Diabetes Watch for Frequent Dose Changes in Diabetes Patients With Very High Blood Sugar
Vaccines Ask Egg-Allergic Patients Getting the Flu Vaccine to Describe Their Reaction
Pediatrics Get a Child's Weight When They're Getting a Liquid Heart Med
Practice a new website for Pharmacy Technician's Letter